SCHEMBL7333376

SCHEMBL7333376

CN(C(=O)c1cccc(NC(=N)N)c1)c1nc2ccccc2c(=O)o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 4/20 0.54
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 2/20 0.48
POLB P06746 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPK10 P53779 1/20 0.47
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C19 P33261 2/20 0.45
TP53 P04637 2/20 0.45
NPC1 O15118 1/20 0.45
CYP2C9 P11712 1/20 0.45
RAB9A P51151 1/20 0.45
HPGD P15428 1/20 0.45
USP2 O75604 1/20 0.45
CYP2D6 P10635 1/20 0.45
GAA P10253 1/20 0.44
C1R P00736 6/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7333378 0.90 ELANE (0.50) ELANEMEN1KMT2AALDH1A1KDM4E
SCHEMBL7338273 0.90 ELANE (0.58) ELANEALDH1A1KDM4EHPGDGAA
SCHEMBL7337855 0.89 ELANE (0.48) ELANEMEN1KMT2AALDH1A1KDM4E
SCHEMBL7332655 0.86 ELANE (0.59) ELANEC1RPRSS1
SCHEMBL7330017 0.82 C1R (0.48) ELANEMEN1KMT2AALDH1A1KDM4E
SCHEMBL7333539 0.81 ELANE (0.74) ELANESMN1; SMN2TP53NPC1RAB9A
SCHEMBL7329441 0.81 ELANE (0.63) ELANEC1RPRSS1
SCHEMBL7332556 0.80 TP53 (0.48) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL7365932 0.80 ELANE (0.62) ELANEC1RPRSS1
SCHEMBL7336411 0.80 ELANE (0.43) ELANEMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5652237-A 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes WARNER-LAMBERT COMPANY (US) 1997-07-29 US claimed
WO-1996007648-A1 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES WARNER-LAMBERT COMPANY (US) 1996-03-14 WO claimed
US-5652237-A 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes WARNER-LAMBERT COMPANY (US) 1997-07-29 US disclosed
WO-1996007648-A1 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES WARNER-LAMBERT COMPANY (US) 1996-03-14 WO disclosed